Walleye Trading’s AMAG Pharmaceuticals AMAG Stock Holding History

Walleye Trading’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,100	Closed	-$85K	–	4897
2020 Q2	$85K	Buy	11,100 +8,400	+311%	+$64.3K	﹤0.01%	3595
2020 Q1	$17K	Buy	+2,700	New	+$23.8K	﹤0.01%	3655
2019 Q1	–	Sell	-3,700	Closed	-$56K	–	5022
2018 Q4	$56K	Sell	3,700 -25,900	-88%	-$494K	﹤0.01%	4103
2018 Q3	$592K	Buy	+29,600	New	+$674K	﹤0.01%	2690
2017 Q4	–	Sell	-2,500	Closed	-$46	–	4773
2017 Q3	$46	Sell	2,500 -1,300	-34%	-$24.2K	﹤0.01%	3821
2017 Q2	$71	Buy	+3,800	New	+$75.3K	﹤0.01%	3726

Walleye Trading's AMAG Position: Q2 2020 in Review

Walleye Trading sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 9,627 shares — an estimated $73.7K sold.

Walleye Trading first reported a position in AMAG in Q2 2015 and held it in 8 quarters. The position peaked at $390K in Q4 2016. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

Walleye Trading reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Walleye Trading sold 9,627 AMAG Pharmaceuticals shares in Q2 2020, an estimated $73.7K.
Walleye Trading first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 8 quarters.
Walleye Trading's AMAG Pharmaceuticals position peaked at $390K in Q4 2016.
119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.